| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Royalty Pharma plc - 8-K, Current Report | 2 | SEC Filings | ||
| Di | Royalty Pharma plc: Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million | 231 | GlobeNewswire (Europe) | Vorasidenib, if approved, would be the first targeted therapy in IDH-mutant glioma, a progressive and incurable brain tumorPivotal Phase 3 clinical study of vorasidenib demonstrated unprecedented... ► Artikel lesen | |
| 22.05. | Royalty Pharma plc; Cytokinetics: Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline | 5 | GlobeNewswire (USA) | ||
| 13.05. | Royalty Pharma plc: Royalty Pharma to Present at Upcoming Investor Conferences | 2 | GlobeNewswire (USA) | ||
| 09.05. | Royalty Pharma plc - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 09.05. | Royalty Pharma plc - 8-K, Current Report | 5 | SEC Filings | ||
| 09.05. | Royalty Pharma plc: Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab | 1.311 | GlobeNewswire (Europe) | Frexalimab is in Phase 3 development by Sanofi in multiple sclerosis with multi-blockbuster potential in a wide range of immune-mediated diseasesExpands Royalty Pharma's development-stage portfolio... ► Artikel lesen | |
| 19.04. | Royalty Pharma plc: Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 | 4 | GlobeNewswire (USA) | ||
| 17.04. | Royalty Pharma plc: Royalty Pharma Declares Second Quarter 2024 Dividend | 2 | GlobeNewswire (USA) | ||
| 28.02. | Royalty Pharma plc: Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference | 4 | GlobeNewswire (USA) | ||
| 15.02. | Royalty Pharma PLC reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
| 15.02. | Royalty Pharma plc - 10-K, Annual Report | - | SEC Filings | ||
| 15.02. | Royalty Pharma plc: Royalty Pharma Reports Q4 and Full Year 2023 Results | 659 | GlobeNewswire (Europe) | Portfolio Receipts of $736 million in Q4 2023 and $3,049 million for FY 2023Net cash provided by operating activities of $773 million in Q4 2023 and $2,988 million for FY 2023Announced transactions... ► Artikel lesen | |
| 15.02. | Royalty Pharma plc - 8-K, Current Report | 1 | SEC Filings | ||
| 06.02. | Royalty Pharma plc - 8-K, Current Report | 5 | SEC Filings | ||
| 30.01. | Royalty Pharma plc: Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024 | 7 | GlobeNewswire (USA) | ||
| 19.01. | Royalty Pharma plc: Royalty Pharma Announces Dividend Increase | 3 | GlobeNewswire (USA) | ||
| 08.01. | Royalty Pharma plc - 8-K, Current Report | 5 | SEC Filings | ||
| 27.12.23 | Royalty Pharma plc - 8-K, Current Report | 3 | SEC Filings |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 589 |
| NVIDIA | 480 |
| EVOTEC | 475 |
| BIONTECH | 343 |
| BAYER | 298 |
| TUI | 298 |
| VOLKSWAGEN | 236 |
| GAMESTOP | 231 |
| PLUG POWER | 218 |
| RHEINMETALL | 205 |
| BYD | 169 |
| SALESFORCE | 142 |
| DELL TECHNOLOGIES | 121 |
| BASF | 120 |
| AIXTRON SE | 118 |
| DEUTSCHE LUFTHANSA | 117 |
| MERCEDES-BENZ | 113 |
| TESLA | 112 |
| SUPER MICRO COMPUTER | 102 |
| DEUTSCHE TELEKOM | 101 |
| SIEMENS ENERGY | 95 |
| AMAZON | 92 |
| DEUTSCHE BANK | 92 |
| NIO INC ADR | 91 |
| MICROSOFT | 87 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
